Journal Article (Letter)

DZNE-2025-01209

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Methotrexate therapy as a promising long-term treatment approach for immune-mediated adverse reactions of tofersen in SOD1-ALS: a case report.

Vidovic, M. ; Lapp, H. S. ; Dittes, I. ; Leuchten, N. ; Aringer, M. ; Günther, C. ; Günther, R. (Last author)DZNE*

2025
Steinkopff [Darmstadt]

This record in other databases:    

Please use a persistent id in citations: doi:10.1007/s00415-025-13415-3

Keyword(s): SOD1-ALS ; Adverse reactions ; Autoimmune ; Immune-mediated ; Immunosuppression ; Methotrexate ; Myelitis ; Tofersen

---

Contributing Institute(s):

1. Translational Parkinson Research (AG Falkenburger)

Research Program(s):

1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)

Appears in the scientific report 2025

---

Database coverage:
; ; ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DEAL Springer ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 5 ; JCR ; Nationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---